UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20449
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF
THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER
SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number: 1-9813
GENENTECH, INC.
(Exact name of registrant as specified in its charter)
1 DNA Way
South San Francisco, CA 94080
(650) 225-1000
(Address, including zip code, and telephone number, including area code, of
registrant's principal executive offices)
Callable Putable Common Stock, Par Value $.02 Per Share
(Title of each class of securities covered by this Form)
None
(Title of all other classes of securities for which a duty to file reports
under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)(i) |X| Rule 12h-3(b)(1)(i) |X|
Rule 12g-4(a)(1)(ii) |_| Rule 12h-3(b)(1)(ii) |_|
Rule 12g-4(a)(2)(i) |_| Rule 12h-3(b)(2)(i) |_|
Rule 12g-4(a)(2)(ii) |_| Rule 12h-3(b)(2)(ii) |_|
Rule 15d-6 |_|
Approximate number of holders of record as of the certification or notice
date: None
Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, Genentech, Inc. has caused this certification/notice to be signed on
its behalf by the undersigned duly authorized person.
GENENTECH, INC.
Date: June 16, 1999 By: /s/ Stephen G. Juelsgaard
----------------------------------------
Name: Stephen G. Juelsgaard
Title: Senior Vice President,
General Counsel and Secretary
